MiniMed Instinct CGM Sensor

Instinct Sensor, Instinct CGM, MiniMed CGM

Introducing the new Instinct sensor, made by Abbott

Abbott designed the Instinct sensor for exclusive use with the MiniMed™ 780G system. Together, this integrated system delivers real-time glucose data, automatically adjusts insulin delivery, and provides proactive alerts—helping you spend less time managing your diabetes and more time living your life.

Instinct CGM sensor, MiniMed CGM, Abbott

Insertion

Easy, one-handed placement.

Design

Small, discreet (about the size of two stacked pennies) with no overtape.

Duration

15-day wear time with a 1-hour warmup.

Compatability

No fingersticks required with SmartGuard™ technology; indicated for people with Type 1 diabetes

Instinct CGM, Instinct Sensor, MiniMed Sensor, MiniMed CGM

The MiniMed 780G system paired with the Instinct sensor from Abbott is the newest dynamic duo in diabetes care! Experience the full power of the MiniMed 780G system—including Meal Detection™ technology that adjusts and corrects every five minutes—now combined with the world’s smallest¹², 15-day-wear sensor.

What is the Instinct sensor?

The Instinct sensor is a continuous glucose monitoring (CGM) sensor created exclusively for use with the MiniMed™ 780G system. It provides real-time glucose readings to support automated insulin delivery. Learn more in the User Guide.

How long can I wear the Instinct sensor?

The sensor offers a 15-day wear time, helping reduce insertion frequency and support uninterrupted glucose monitoring.

Does the Instinct sensor integrate with MiniMed insulin pumps?

The Instinct sensor is designed exclusively for the MiniMed™ 780G system and is not compatible with other insulin delivery systems.

Who is the Instinct sensor designed for?

The Instinct sensor is indicated for people with Type 1 diabetes using the MiniMed™ 780G insulin pump system.

Is the Instinct sensor covered by insurance?

The Instinct sensor is covered by many commercial insurance plans for those who qualify. Medicaid and Medicare coverage is pending, with approval expected in early 2026. Some plans require CGMs to be billed under the pharmacy benefit rather than as DME. EHCS will verify your eligibility and coverage, and you may be served by our sister company, GEM Edwards Pharmacy, if needed.

Is the Instinct the only CGM from MiniMed?

For the MiniMed 780G insulin pump, the Instinct sensor and the Guardian 4 sensors are available. MiniMed also offers the Simplera CGM that works with the InPen; this is available from our sister company, GEM Edwards Pharmacy. Click here to view a comparison chart of the available MiniMed CGM sensors.

———- Discover More ———-

Introducing the New Instinct Sensor

Getting Started with the Instinct Sensor

Ready to get started with a MiniMed system?

At EHCS, our goal is to provide you with a first-rate customer experience through the entire process. After you complete our online form, a Diabetes Care Advisor will reach out to help you through the process. From insurance approval and product selection to future reorders, our team of DCAs is your guide to better diabetes control.

Footnotes
† Refers to SmartGuard™ technology. Individual results may vary.
‡ Fingersticks required in manual mode & to enter SmartGuard™. If symptoms don’t match alerts & readings, use a fingerstick. Refer to user guide. Pivotal trial participants spend avg of > 93% in SmartGuard.

References
1. Data on file, Abbott Diabetes Care, Inc.

Important Safety Information: MiniMed™ 780G system with SmartGuard™ technology with Instinct™ sensor

The MiniMed™ 780G system is intended for continuous delivery of basal insulin at selectable rates, and the administration of insulin boluses at selectable amounts for the management of type 1 diabetes mellitus in persons seven years of age and older requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed™ 780G System includes SmartGuard™ technology, which can be programmed to automatically adjust insulin delivery based on the continuous glucose monitoring (CGM) sensor glucose values and can suspend delivery of insulin when the sensor glucose (SG) value falls below or is predicted to fall below predefined threshold values.

The Instinct sensor can be used one time and has a life up to 15 days. The Instinct sensor is not intended to be used directly to make therapy adjustments while the MiniMed™ 780G system is operating in manual mode. All therapy adjustments in Manual mode should be based on measurements obtained using a blood glucose meter and not on values provided by the Instinct sensor. The Instinct sensor has been studied and is approved for use in patients ages 7 years and older and in the arm insertion site only. Only apply the sensor to the back of your upper arm. The sensor may not work properly in other areas.

The Medtronic MiniMed™ 780G System consists of the following devices: MiniMed™ 780G Insulin Pump and the Instinct sensor. The system requires a prescription from a healthcare professional.

WARNING: Do not use the SmartGuard™ feature for people who require less than 8 units or more than 250 units of total daily insulin per day. A total daily dose of at least 8 units, but no more than 250 units, is required to operate in the SmartGuard™ feature.

WARNING: Do not use the MiniMed™ 780G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMed™ 780G system.

WARNING: Do not use SG values to make treatment decisions, including delivering a bolus, while the pump is in Manual Mode. When the SmartGuard™ feature is active and you are no longer in Manual Mode, the pump uses an SG value, when available, to calculate a bolus amount. However, if your symptoms do not match the SG value, use a blood glucose (BG) meter to confirm the SG value. Failure to confirm glucose levels when your symptoms do not match the SG value can result in the infusion of too much or too little insulin, which may cause hypoglycemia or hyperglycemia.

Pump therapy is not recommended for people whose vision or hearing does not allow for the recognition of pump signals, alerts, or alarms. The safety of the MiniMed™ 780G system has not been studied in pregnant women, persons with type 2 diabetes, or in persons using other anti-hyperglycemic therapies that do not include insulin. For complete details of the system, including product and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, please consult https://www.medtronicdiabetes.com/important-safety-information and the appropriate user guide at https://www.medtronicdiabetes.com/download-library.

Your Cart